MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

    C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

    Objective: Refine understanding of the processes underpinning apathy in neurodegenerative disease, by identifying 1) objective measures to assess apathy; 2) parcellating the broad construct of…
  • 2016 International Congress

    Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

    J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

    Objective: To examine the accuracy, effectiveness, and utility of a novel virtual reality (VR) simulation representing symptoms of Parkinson's disease psychosis (PDP). Background: Diagnosing PDP…
  • 2016 International Congress

    Standardized assessment of camptocormia in idiopathic Parkinson’s disease

    T. Schmidt, G. Ebersbach, G. Doreen (Beelitz-Heilstätten, Germany)

    Objective: The present study aimed to develop a clinical algorithm to comprehensively characterize CC in PD. Background: Clinical assessment of Camptocormia (CC) in Parkinson's disease…
  • 2016 International Congress

    Comparative analysis of upper limb motor function and articulation disorder in Parkinson’s disease

    E. Ruzicka, J. Rusz, T. Tykalova, K. Zarubova, R. Krupicka, R. Jech (Prague, Czech Republic)

    Objective: To assess the relationship between upper limb bradykinesia and hypokinetic dysarthria in Parkinson's disease (PD) using instrumental investigations of speech and limb motor function.…
  • 2016 International Congress

    Freezing of gait in extrapontine myelinolysis

    Y.N. Kwon, D. Lee, T.B. Ahn (Jindo-gun, Korea)

    Background: Extrapontine myelinolysis (EPM) is rarely complicated with akinetic-rigid parkinsonism. Herein we report a case with EPM presenting with freezing of gait (FOG). Methods: Case…
  • 2016 International Congress

    Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…
  • 2016 International Congress

    Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation

    H. Eggink, M.E. van Egmond, M.C. Schönherr, C.C. Verschuuren-Bemelmans, T.J. de Koning, M.J.C. van Dijk, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To report on two patients with dystonia-deafness syndrome associated with a mutation in the beta actin gene and a positive effect of pallidal deep…
  • 2016 International Congress

    Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions

    M.S. Jog, R.M. Jog, A. Tewari, D. Hobson, D. Stewart, D. King (London, ON, Canada)

    Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…
  • 2016 International Congress

    Botulinum toxin A injections changes sensorimotor network activations in cervical dystonia to state more related to physiological condition

    M. Nevrly, P. Hlustik, P. Otruba, P. Hok, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To evaluate botulinum toxin A (BoNT-A) effectiveness on network in sensorimotor circuits. Background: Involvement of many cerebellar structures, such basal ganglia, thalamus, cerebellum, premotor…
  • 2016 International Congress

    Frequency and types of dystonia in Wilson’s disease patients

    K. Dziezyc, T. Litwin, G. Chabik, A. Czlonkowska (Warsaw, Poland)

    Objective: To establish the frequency and types of dystonia in our cohort of Wilson's disease patients. Background: Wilson's disease (WD) belongs to movement disorders with…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Determinants of quality of life in a large, online cohort of patients with Parkinson’s disease
  • Defining minimal clinically important differences in Huntington’s disease: An anchor-based approach
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley